Elevance Health revenue and financials

ELV · NYSE · USD

$400.09Change from previous close: +1.41%Absolute change: +$5.58

Close · October 6, 2026

In the fiscal year ended December 2025, Elevance Health reported revenue of $199.13B (+12.49% year over year). Net income was $5.66B, a net margin of 2.8%.

Annual revenue · 2025: $199.13B
  1. $84.86B2016
  2. $90.04B2017
  3. $92.11B2018
  4. $104.21B2019
  5. $121.87B2020
  6. $138.64B2021
  7. $156.6B2022
  8. $171.34B2023
  9. $177.01B2024
  10. $199.13B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+12.49%
2025 vs 2024
Net income growth
−5.32%
2025 vs 2024
Net margin
2.8%
2024: 3.4%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Balance sheet · Quarterly
ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Total assets126,438125,827121,494122,749121,938119,717116,889116,533112,988111,894108,928110,478
Cash and equivalents10,2329,6579,4918,7138,5607,5008,2887,8666,4976,2266,52610,919
Short-term investments25,71925,90525,88426,28325,298———————
Receivables23,39222,79021,54222,34923,125———————
Net property, plant and equipment4,6454,6575,1314,6574,6414,6175,2194,5054,4504,4514,9434,821
Goodwill28,33928,34028,34428,45128,36828,42028,27725,96725,96225,94725,31725,291
Other intangible assets10,98311,09311,20011,32711,490———————
Long-term investments28,54128,53027,74528,61427,319———————
Accounts payable25,09524,63424,40623,23324,433———————
Long-term debt30,66930,76830,84131,17328,17828,11029,36824,68824,56121,97623,24624,045
Total debt31,04431,84232,04632,10230,186———————
Total liabilities81,41681,78577,46878,66778,087———————
Total equity (incl. minority)45,02244,04244,02644,08243,85142,62041,42643,87942,29740,71039,40538,539
Retained earnings36,67535,79635,39335,58635,54934,54633,54935,15734,57533,08831,74932,103
Minority interest13914014412912911711110410610299.0116